Wednesday, 17 Oct 2018

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

The Week in Review: 5 February 2016

08 Feb 2016

Dr. Cassie Calabrese: Immune-related...

14 Jun 2017

Dr. Cassandra Calabrese: Checkpoint...

07 Nov 2017

Paul Emery, MD: biosimilar etanercept...

11 Nov 2015

Dr. Janet Pope: Pre-op for Total Hip or...

07 Nov 2017

Dr. Susan Goodman - Newly Released ACR/...

20 Jun 2017

EULAR 2016 Round-Up - Dr. Jack Cush

19 Jun 2016

RWCS 2017: Etanercept-induced...

21 Feb 2017

Dr. Jack Cush and Rheumatology Winter...

18 Nov 2017

Dr. Jack Cush: The Hot Seat Cases

09 Feb 2018

The RheumNow Week in Review – 4 August...

04 Aug 2017

Dr. Cassandra Calabrese: Efficacy of...

05 Nov 2017